PAG
MDT icon

Paladin Advisory Group’s Medtronic MDT Stock Holding History

Paladin Advisory Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-170
Closed -$13.2K – 405
2022
Q4 		$13.2K Sell
170
-461
-73% -$37.4K 0.01% 210
2022
Q3 		$50K Hold
631
– – 0.05% 158
2022
Q2 		$56K Buy
+631
New +$63.9K 0.05% 153
2022
Q1 		– Sell
-631
Closed -$65K – 419
2021
Q4 		$65K Buy
+631
New +$73.1K 0.05% 160

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paladin Advisory Group's MDT Position: Q4 2024 in Review

Paladin Advisory Group sold out of Medtronic (MDT) in Q4 2024, closing a stake of 132 shares — an estimated $11.9K sold.

Paladin Advisory Group first reported a position in MDT in Q1 2022 and held it in 8 quarters. The position peaked at $71K in Q1 2022. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Paladin Advisory Group reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Paladin Advisory Group sold 132 Medtronic shares in Q4 2024, an estimated $11.9K.
  • Paladin Advisory Group first reported a position in Medtronic in Q1 2022 and held it in 8 quarters.
  • Paladin Advisory Group's Medtronic position peaked at $71K in Q1 2022.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Paladin Advisory Group's 13F filing for Q4 2024, filed 23 Jan 2025.